James Yang

18PUBLICATIONS
140CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|May 06, 2026
Correlation between recognition of autologous tumor organoids by tumor-infiltrating lymphocytes from metastatic epithelial cancers and clinical response.

|Apr 29, 2026
Vaccination rescues dysfunctional T cell therapy by amplifying rare stem-like antitumor CD8<sup>+</sup> T cells.

|Nov 30, 2025
The science of tumor-infiltrating lymphocytes (TIL): perspectives from the SITC Surgery Committee.

George Coukos, Marco Donia, Brian R Gastman

|Sep 30, 2025
Expression of IMPACT Curtails Metabolic Plasticity and Augments NK Cell Killing to Abrogate Metastatic Growth.

Surajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves

|Jul 30, 2025
Expression of IMPACT curtails metabolic plasticity and augments NK cell killing to abrogate metastatic growth.

Surajit Sinha, Abir Kumar Panda, Rodrigo Xavier das Neves

|Jul 21, 2025
Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up.

Tatyana Gavrilova, Lori McIntyre, Stephanie L Goff

Pageof 3

Frequent Collaborators

12 joint publications

Stephanie L Goff

9 joint publications

Paul Robbins

7 joint publications

Jared J Gartner

6 joint publications

Sri Krishna